BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

604 related articles for article (PubMed ID: 33035728)

  • 1. Combined multiple clinical characteristics for prediction of discordance in grade and stage in prostate cancer patients undergoing systematic biopsy and radical prostatectomy.
    Liu H; Tang K; Xia D; Peng E; Wang L; Chen Z
    Pathol Res Pract; 2020 Nov; 216(11):153235. PubMed ID: 33035728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nomogram Predicting Downgrading in National Comprehensive Cancer Network High-risk Prostate Cancer Patients Treated with Radical Prostatectomy.
    Wenzel M; Würnschimmel C; Chierigo F; Flammia RS; Tian Z; Shariat SF; Gallucci M; Terrone C; Saad F; Tilki D; Graefen M; Becker A; Kluth LA; Mandel P; Chun FKH; Karakiewicz PI
    Eur Urol Focus; 2022 Sep; 8(5):1133-1140. PubMed ID: 34334344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gleason sum upgrading between biopsy and radical prostatectomy in Chinese population: Updated nomograms.
    Xu H; Bai PD; Hu MB; Mao SH; Zhu WH; Hu JM; Liu SH; Yang T; Hou JY; Hu Y; Ding Q; Jiang HW
    Actas Urol Esp; 2017 Apr; 41(3):162-171. PubMed ID: 27522521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting Gleason sum upgrading from biopsy to radical prostatectomy pathology: a new nomogram and its internal validation.
    Wang X; Zhang Y; Zhang F; Ji Z; Yang P; Tian Y
    BMC Urol; 2021 Jan; 21(1):3. PubMed ID: 33407381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple Tissue Biomarkers Independently and Additively Predict Prostate Cancer Pathology Outcomes.
    Cooperberg MR; Cowan JE; Lindquist KJ; Kobayashi Y; Simko JP; Bengtsson H; Singh K; Ngo V; Avila A; Newcomb LF; Tretriakova M; Lin DW; Stone S; Carroll PR; Paris PL
    Eur Urol; 2021 Jan; 79(1):141-149. PubMed ID: 33148472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperative MRI PI-RADS scores are associated with prostate cancer upstaging on surgical pathology.
    Pockros B; Stensland KD; Parries M; Frankenberger E; Canes D; Moinzadeh A
    Prostate; 2022 Feb; 82(3):352-358. PubMed ID: 34878175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A nomogram to predict Gleason sum upgrading of clinically diagnosed localized prostate cancer among Chinese patients.
    Wang JY; Zhu Y; Wang CF; Zhang SL; Dai B; Ye DW
    Chin J Cancer; 2014 May; 33(5):241-8. PubMed ID: 24559852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. External validation and comparison of two nomograms predicting the probability of Gleason sum upgrading between biopsy and radical prostatectomy pathology in two patient populations: a retrospective cohort study.
    Utsumi T; Oka R; Endo T; Yano M; Kamijima S; Kamiya N; Fujimura M; Sekita N; Mikami K; Hiruta N; Suzuki H
    Jpn J Clin Oncol; 2015 Nov; 45(11):1091-5. PubMed ID: 26292699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. External validation of the updated nomogram predicting lymph node invasion in patients with prostate cancer undergoing extended pelvic lymph node dissection.
    Gacci M; Schiavina R; Lanciotti M; Masieri L; Serni S; Vagnoni V; Abdollah F; Carini M; Martorana G; Montorsi F
    Urol Int; 2013; 90(3):277-82. PubMed ID: 23296120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upgrading and downgrading of prostate cancer from biopsy to radical prostatectomy: incidence and predictive factors using the modified Gleason grading system and factoring in tertiary grades.
    Epstein JI; Feng Z; Trock BJ; Pierorazio PM
    Eur Urol; 2012 May; 61(5):1019-24. PubMed ID: 22336380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparing histology between prostate cognitive fusion targeted biopsy and radical prostatectomy: exploring risk factors of Gleason score upgrading in Chinese patients.
    Zheng T; Sun H; Tang Y; Bi K; Zeng Y; Wang J; Yan L
    J Cancer Res Clin Oncol; 2023 Dec; 149(20):18029-18037. PubMed ID: 37979056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. External validation of a nomogram predicting the probability of prostate cancer Gleason sum upgrading between biopsy and radical prostatectomy pathology among Japanese patients.
    Imamoto T; Suzuki H; Utsumi T; Takano M; Suyama T; Kawamura K; Kamiya N; Naya Y; Ueda T; Ichikawa T
    Urology; 2010 Aug; 76(2):404-10. PubMed ID: 19716590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nomograms for predicting Gleason upgrading in a contemporary Chinese cohort receiving radical prostatectomy after extended prostate biopsy: development and internal validation.
    He B; Chen R; Gao X; Ren S; Yang B; Hou J; Wang L; Yang Q; Zhou T; Zhao L; Xu C; Sun Y
    Oncotarget; 2016 Mar; 7(13):17275-85. PubMed ID: 26943768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a new nomogram to predict insignificant prostate cancer in patients undergoing radical prostatectomy.
    Kim TH; Jeon HG; Jeong BC; Seo SI; Jeon SS; Choi HY; Lee HM
    Scand J Urol; 2017 Feb; 51(1):27-32. PubMed ID: 28168924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A nomogram for predicting upgrading in patients with low- and intermediate-grade prostate cancer in the era of extended prostate sampling.
    Moussa AS; Kattan MW; Berglund R; Yu C; Fareed K; Jones JS
    BJU Int; 2010 Feb; 105(3):352-8. PubMed ID: 19681898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel nomogram to identify candidates for active surveillance amongst patients with International Society of Urological Pathology (ISUP) Grade Group (GG) 1 or ISUP GG2 prostate cancer, according to multiparametric magnetic resonance imaging findings.
    Luzzago S; de Cobelli O; Cozzi G; Peveri G; Bagnardi V; Catellani M; Di Trapani E; Mistretta FA; Pricolo P; Conti A; Alessi S; Marvaso G; Ferro M; Matei DV; Renne G; Jereczek-Fossa BA; Petralia G; Musi G
    BJU Int; 2020 Jul; 126(1):104-113. PubMed ID: 32150328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proportion of cores with the highest Gleason grade group among positive cores on prostate biopsy: does this affect the probability of upgrading or downgrading?
    Yoo S; Suh J; Park J; Cho MC; Son H; Jeong H
    Scand J Urol; 2019 Dec; 53(6):372-377. PubMed ID: 31674877
    [No Abstract]   [Full Text] [Related]  

  • 18. Downgrading of grade group 2 intermediate-risk prostate cancer from biopsy to radical prostatectomy: Comparison of outcomes and predictors to identify potential candidates for active surveillance.
    Su ZT; Patel HD; Epstein JI; Pavlovich CP; Allaf ME
    Cancer; 2020 Apr; 126(8):1632-1639. PubMed ID: 32031685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radical prostatectomy in men aged >or=70 years: effect of age on upgrading, upstaging, and the accuracy of a preoperative nomogram.
    Richstone L; Bianco FJ; Shah HH; Kattan MW; Eastham JA; Scardino PT; Scherr DS
    BJU Int; 2008 Mar; 101(5):541-6. PubMed ID: 18257855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postoperative upgrading of prostate cancer in men ≥75 years: a propensity score-matched analysis.
    Herlemann A; Buchner A; Kretschmer A; Apfelbeck M; Stief CG; Gratzke C; Tritschler S
    World J Urol; 2017 Oct; 35(10):1517-1524. PubMed ID: 28493044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.